JP2008502717A - 放射性標識ハロゲン化キサンテンを使用する陽電子放出イメージング用の診断薬および放射性標識ハロゲン化キサンテン診断薬による陽電子放出イメージング方法 - Google Patents

放射性標識ハロゲン化キサンテンを使用する陽電子放出イメージング用の診断薬および放射性標識ハロゲン化キサンテン診断薬による陽電子放出イメージング方法 Download PDF

Info

Publication number
JP2008502717A
JP2008502717A JP2007527319A JP2007527319A JP2008502717A JP 2008502717 A JP2008502717 A JP 2008502717A JP 2007527319 A JP2007527319 A JP 2007527319A JP 2007527319 A JP2007527319 A JP 2007527319A JP 2008502717 A JP2008502717 A JP 2008502717A
Authority
JP
Japan
Prior art keywords
radiolabeled
hexaiodofluorescein
halogenated xanthene
diagnostic agent
xanthene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007527319A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008502717A5 (es
Inventor
シー． スコット ティモシー
エッチ． ディーズ クレイグ
エー． ワクター エリック
Original Assignee
ザンテック ファーマスーティカルズ，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/050,512 external-priority patent/US7338652B2/en
Priority claimed from US11/049,797 external-priority patent/US7427389B2/en
Application filed by ザンテック ファーマスーティカルズ，インク． filed Critical ザンテック ファーマスーティカルズ，インク．
Publication of JP2008502717A publication Critical patent/JP2008502717A/ja
Publication of JP2008502717A5 publication Critical patent/JP2008502717A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K51/0421—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2007527319A 2004-06-10 2005-05-13 放射性標識ハロゲン化キサンテンを使用する陽電子放出イメージング用の診断薬および放射性標識ハロゲン化キサンテン診断薬による陽電子放出イメージング方法 Pending JP2008502717A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57862204P 2004-06-10 2004-06-10
US11/050,512 US7338652B2 (en) 2004-06-10 2005-02-03 Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents
US11/049,797 US7427389B2 (en) 2004-06-10 2005-02-03 Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes
PCT/US2005/016836 WO2006001925A1 (en) 2004-06-10 2005-05-13 Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes and methods for positron emission imaging with radiolabeled halogenated xanthene diagnostic agents

Publications (2)

Publication Number Publication Date
JP2008502717A true JP2008502717A (ja) 2008-01-31
JP2008502717A5 JP2008502717A5 (es) 2008-06-19

Family

ID=35782109

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007527319A Pending JP2008502717A (ja) 2004-06-10 2005-05-13 放射性標識ハロゲン化キサンテンを使用する陽電子放出イメージング用の診断薬および放射性標識ハロゲン化キサンテン診断薬による陽電子放出イメージング方法

Country Status (6)

Country Link
EP (1) EP1753467B1 (es)
JP (1) JP2008502717A (es)
CA (1) CA2570687C (es)
ES (1) ES2398962T3 (es)
MX (1) MXPA06014266A (es)
WO (1) WO2006001925A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0613287D0 (en) * 2006-07-05 2006-08-16 Ge Healthcare Ltd Dye imaging agents
US8530675B2 (en) * 2009-09-18 2013-09-10 Provectus Pharmaceuticals, Inc. Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (rose bengal) and related xanthenes
GB201019303D0 (en) 2010-11-15 2010-12-29 Strom Hans E P Agents and methods for visualising analytes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000344684A (ja) * 1999-03-26 2000-12-12 Bf Kenkyusho:Kk ピロニンｂ類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物
JP2002533355A (ja) * 1998-12-21 2002-10-08 フォトゲン インク 高エネルギ光線治療薬剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB846674A (en) * 1958-04-29 1960-08-31 Univ Kansas Res Foundation Xanthene compounds and dyestuffs and means of producing the same
US4256727A (en) * 1978-09-18 1981-03-17 The University Of Kentucky Research Foundation Synthesis and use of diagnostic radio-pharmaceuticals comprising radioactive isotopes of bromine with dyes
US7390668B2 (en) * 1996-10-30 2008-06-24 Provectus Pharmatech, Inc. Intracorporeal medicaments for photodynamic treatment of disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002533355A (ja) * 1998-12-21 2002-10-08 フォトゲン インク 高エネルギ光線治療薬剤
JP2000344684A (ja) * 1999-03-26 2000-12-12 Bf Kenkyusho:Kk ピロニンｂ類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物

Also Published As

Publication number Publication date
ES2398962T3 (es) 2013-03-22
WO2006001925A1 (en) 2006-01-05
CA2570687A1 (en) 2006-01-05
EP1753467B1 (en) 2013-01-09
EP1753467A1 (en) 2007-02-21
CA2570687C (en) 2013-07-09
MXPA06014266A (es) 2007-05-23
EP1753467A4 (en) 2008-09-17

Similar Documents

Publication Publication Date Title
Klaassen et al. The various therapeutic applications of the medical isotope holmium-166: a narrative review
Laforest et al. Dosimetry of 60/61/62/64 Cu-ATSM: a hypoxia imaging agent for PET
Larsen et al. 221At-and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation
JP2860157B2 (ja) 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
CN112851637B (zh) 一种psma抑制剂、化合物及其制备方法与用途
Alsharef et al. Review about radiopharmaceuticals: preparation, radioactivity, and applications
Blanco et al. Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles
US7338652B2 (en) Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents
US7427389B2 (en) Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes
JP2008502717A (ja) 放射性標識ハロゲン化キサンテンを使用する陽電子放出イメージング用の診断薬および放射性標識ハロゲン化キサンテン診断薬による陽電子放出イメージング方法
Hodolic et al. Safety and tolerability of 68 Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in-human use
Hajdu et al. A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
Kumar et al. Positron tomographic imaging of the liver: 68 Ga iron hydroxide colloid
Kaur et al. Theranostics: New era in nuclear medicine and radiopharmaceuticals
Fazaeli et al. Preclinical dosimetric estimation of [111In] 5, 10, 15, 20-tetra phenyl porphyrin complex as a possible imaging/PDT agent
Gholipour et al. Chelator-free radiolabeling of dextran with 68Ga for PET studies
KR20000022136A (ko) 신규한 방사성 약제 조성물, 그의 매트릭스 및 용도
Fernandes et al. Nuclear medicine and drug delivery
KR102621851B1 (ko) 포피린 유도체 및 암의 영상화, 진단, 또는 치료용 조성물
Mandiwana et al. Preclinical assessment of 68Ga‐PSMA‐617 entrapped in a microemulsion delivery system for applications in prostate cancer PET/CT imaging
RU2614235C2 (ru) Остеотропный радиофармацевтический препарат для пэт-визуализации
CHILUG et al. Gold nanoparticles-based radiopharmaceuticals for nuclear molecular imaging and therapy applications
JP2006257041A (ja) 心筋用放射性画像診断剤又は放射性治療薬
아룬 Voxel-based dosimetry of iron oxide nanoparticles based 177Lu-labeled folate conjugates targeted SPECT/CT imaging of mice
Okoye Synthesis and preclinical evaluation of peptide receptor-targeted diagnostic and therapeutic radiopharmaceuticals for prostate cancer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080424

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080424

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20101105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20101105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110315

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110614

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110621

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110715

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110725

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110815

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110913

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120508